Cell Counting Market (By Product Type- Instruments and Consumables. By End-user- Pharmaceuticals, Research Institutes and Hospitals and Pathology Labs and By Regions)– Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018 – 2025

The global cell counting market was valued at USD 8.72 Billion in 2017 and is expected to reach at USD 16.17 Billion by 2025 growing at a Compound annual growth rate (CAGR) of 7.1% from 2018 to 2025. The increasing prevalence of deadly diseases such as AIDS and cancer is expected to propel the demand for cell counters as the counting of cells at frequent intervals is very much essential in the diagnostic and treatment process of AIDS and cancer. In addition, rising corporate and public expenditure towards the development of advanced cell imaging tools and equipment coupled with the deployment of technologically improved cell-based research is further estimated to create new necessities and augment the market of growth over the forecast period of 2018-2025.

Hospitals and Pathology Labs segment is estimated to witness significant growth

The global market for cell counting has been segmented based on product type which is further divided into instruments and consumables. Based on end-user, the market has been segmented as pharmaceuticals, research institutes, and hospitals and pathology labs. The increasing investment towards adopting automated cell-based therapeutic equipment coupled with rising numbers of pathology centers and healthcare clinics across the developing nations around the world is expected to drive the hospitals and pathology labs segment to witness the fastest growth in global cell counting market during the forecast period.

North America holds the largest market share by region

The global cell counting market has been geographically segmented into Asia-Pacific, Europe, North America, Latin America, the Middle East and Africa region. In addition to this, North America region holds the largest market share. The reason may be attributed to the presence of established pharmaceutical companies and technologically upgraded research laboratories where cell counting model has been adopted significantly. In addition, government grants and increased public expenditure towards healthcare sector for developing advanced treatment and diagnostic expertise required for treating chronic diseases are further estimated to be the prime factor responsible for the North America region to dominate the market over the years. Asia-Pacific cell counting market is expected to propel at the fastest growth rate owing to the increasing focus in the stem cell research and cancer research coupled with low developing cost across the Asia Pacific region.

Major Players in Cell Counting Market

Some of the key players in the global cell counting market include Abbott Laboratories, Agilent Technologies, Becton, Dickinson and Company, Bio-Rad Laboratories, Danaher Corporation, Ge Healthcare, Merck, PerkinElmer, Siemens Healthineers, and Thermo Fisher Scientific.

The global cell counting market has been segmented into:

Global Cell Counting Market: By Product Type

·         Instruments

o   Hemocytometer

o   Cell Counter

o   Spectrophotometer

o   Hematology Analyzer

o   Flow Cytometer

·         Consumables

o   Assay Kits

o   Reagents

o   Microplates

Global Cell Counting Market: By End-User

·         Pharmaceuticals

·         Research Institutes

·         Hospitals and Pathology Labs

Global Cell Counting Market: By Geography

·         North America

o   U.S.

o   Canada

o   Mexico

·         Europe

o   U.K.

o   France

o   Germany

o   Italy

o   Rest of Europe

·         Asia Pacific

o   India

o   China

o   Japan

o   Rest of Asia Pacific

·         Middle East and Africa

o   South Africa

o   Rest of Middle East and Africa

·         Latin America

o   Brazil

o   Rest of Latin America